5-year Experience of Oral Deferasirox (Exjade) Use Prior to Transplantation in Patients with Iron Overload that Underwent Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): Retrospective Analysis of a Single Center from Turkey

Iron overload (IO) is considered an important cause of mortality and morbidity in patients who undergo allogeneic hematopoietic stem cell transplantation (alloHSCT). Iron chelation is critical in patients with IO prior to transplantation.

Source: Clinical Lymphoma, Myeloma and Leukemia - August 26, 2016 Category: Hematology Authors: Serdar Sivgin, Esra Yildizhan, Neslihan Sanli, Leylagul Kaynar, Gokmen Zararsiz, Bulent Eser, Mustafa Cetin, Ali Unal Source Type: research